Beat on revenue, miss on margin - Kerecis reset still in progress
18/08/26 -"Coloplast delivered a mixed Q3 FY26: revenue beat consensus (+1.2%) but EBIT missed (-1%), with the margin declining for a third straight quarter. The Wound & Tissue Repair division – the ..."
Pages
66
Language
English
Published on
18/08/26
You may also be interested by these reports :
18/08/26
Coloplast delivered a mixed Q3 FY26: revenue beat consensus (+1.2%) but EBIT missed (-1%), with the margin declining for a third straight quarter. ...
18/08/26
SKAN delivered 22.2% net sales growth with a healthy order intake (book to bill ratio at 1.51x for 1H26) and a backlog growing 27.8% compared to the ...
13/08/26
Ottobock continues to deliver, with a strong set of results in 1H26. Core revenues grew by +7.7% (organic +6.7%), largely supported by a strong EMEA ...
12/08/26
Demant reported better-than-expected Q2 results, with robust top-line growth across all segments. Profitability rose by double digits in H1, and ...